OBJECTIVE: MicroRNAs (miR-NAs) affect almost all cell behaviors of human cancers including gastric cancer (GC). However, the biological role of miR-411 in GC remains to be elucidated. MATERIALS AND METHODS: We determined the expression level of miR-411 in GC cell lines. After synthetic miRNAs or SET domain containing 6 (SETD6) expression vectors transfection, cell proliferation, colony formation, and migration were examined. Moreover, the target of miR-411 was identified by luciferase activity reporter assay and Western blot assay. RESULTS: Results revealed that the miR-411 expression was significantly down-regulated in GC cell lines compared with normal colonic epithelial cells. Overexpression of miR-411 inhibits GC cell proliferation, colony formation, and migration, whereas the overexpression of SETD6 promotes cell proliferation, colony formation, and migration. Moreover, SETD6 was identified as a putative target of miR-411. In addition. we showed miR-411 regulates GC cell behaviors by targeting SETD6. The overexpression of SETD6 promoted the activation of the nuclear factor (NF)-kappa B signaling pathway. CONCLUSIONS: These results suggested that miR-411 functions as a tumor suppressor in GC through targeting SETD6/NF-kappa B pathway. Targeting miR-411 may be a novel clue for GC treatment.
第一作者机构:[1]Department of General Surgery, Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, Hebei, P.R. China
通讯作者:
通讯机构:[1]Department of General Surgery, Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, Hebei, P.R. China
推荐引用方式(GB/T 7714):
Bai T-L,Liu Y-B,Li B-H.MiR-411 inhibits gastric cancer proliferation and migration through targeting SETD6[J].EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES.2019,23(8):3344-3350.
APA:
Bai, T-L,Liu, Y-B&Li, B-H.(2019).MiR-411 inhibits gastric cancer proliferation and migration through targeting SETD6.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,23,(8)
MLA:
Bai, T-L,et al."MiR-411 inhibits gastric cancer proliferation and migration through targeting SETD6".EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 23..8(2019):3344-3350